469 related articles for article (PubMed ID: 25756498)
1. Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis.
Ciaranello AL; Myer L; Kelly K; Christensen S; Daskilewicz K; Doherty K; Bekker LG; Hou T; Wood R; Francke JA; Wools-Kaloustian K; Freedberg KA; Walensky RP
PLoS One; 2015; 10(3):e0117751. PubMed ID: 25756498
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe.
Ciaranello AL; Perez F; Engelsmann B; Walensky RP; Mushavi A; Rusibamayila A; Keatinge J; Park JE; Maruva M; Cerda R; Wood R; Dabis F; Freedberg KA
Clin Infect Dis; 2013 Feb; 56(3):430-46. PubMed ID: 23204035
[TBL] [Abstract][Full Text] [Related]
3. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
[TBL] [Abstract][Full Text] [Related]
4. The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.
Dunning L; Francke JA; Mallampati D; MacLean RL; Penazzato M; Hou T; Myer L; Abrams EJ; Walensky RP; Leroy V; Freedberg KA; Ciaranello A
PLoS Med; 2017 Nov; 14(11):e1002446. PubMed ID: 29161262
[TBL] [Abstract][Full Text] [Related]
5. Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysis.
Dunning L; Gandhi AR; Penazzato M; Soeteman DI; Revill P; Frank S; Phillips A; Dugdale C; Abrams E; Weinstein MC; Newell ML; Collins IJ; Doherty M; Vojnov L; Fassinou Ekouévi P; Myer L; Mushavi A; Freedberg KA; Ciaranello AL
J Int AIDS Soc; 2021 Jan; 24(1):e25651. PubMed ID: 33474817
[TBL] [Abstract][Full Text] [Related]
6. Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study.
Frank SC; Cohn J; Dunning L; Sacks E; Walensky RP; Mukherjee S; Dugdale CM; Turunga E; Freedberg KA; Ciaranello AL
Lancet HIV; 2019 Mar; 6(3):e182-e190. PubMed ID: 30737187
[TBL] [Abstract][Full Text] [Related]
7. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
Ciaranello AL; Perez F; Maruva M; Chu J; Engelsmann B; Keatinge J; Walensky RP; Mushavi A; Mugwagwa R; Dabis F; Freedberg KA;
PLoS One; 2011; 6(6):e20224. PubMed ID: 21655097
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
9. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
10. Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis.
McCann NC; Cohn J; Flanagan C; Sacks E; Mukherjee S; Walensky RP; Adetunji O; Maeka KK; Panella C; Chadambuka A; Mafaune H; Odhiambo C; Freedberg KA; Ciaranello AL
J Acquir Immune Defic Syndr; 2020 Jul; 84 Suppl 1(1):S12-S21. PubMed ID: 32520910
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa.
Dugdale CM; Phillips TK; Myer L; Hyle EP; Brittain K; Freedberg KA; Cunnama L; Walensky RP; Zerbe A; Weinstein MC; Abrams EJ; Ciaranello AL;
PLoS One; 2019; 14(11):e0225104. PubMed ID: 31730630
[TBL] [Abstract][Full Text] [Related]
13. Vertical transmission of HIV among pregnant women who initially had false-negative rapid HIV tests in four South African antenatal clinics.
Mayaphi SH; Martin DJ; Quinn TC; Stoltz AC
PLoS One; 2019; 14(12):e0226391. PubMed ID: 31860677
[TBL] [Abstract][Full Text] [Related]
14. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy.
Mnyani CN; McIntyre JA; Myer L
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):260-4. PubMed ID: 22487589
[TBL] [Abstract][Full Text] [Related]
15. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.
Ciaranello AL; Lockman S; Freedberg KA; Hughes M; Chu J; Currier J; Wood R; Holmes CB; Pillay S; Conradie F; McIntyre J; Losina E; Walensky RP;
AIDS; 2011 Feb; 25(4):479-92. PubMed ID: 21293199
[TBL] [Abstract][Full Text] [Related]
16. Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE).
Woldesenbet S; Jackson D; Lombard C; Dinh TH; Puren A; Sherman G; Ramokolo V; Doherty T; Mogashoa M; Bhardwaj S; Chopra M; Shaffer N; Pillay Y; Goga A;
PLoS One; 2015; 10(7):e0132425. PubMed ID: 26147598
[TBL] [Abstract][Full Text] [Related]
17. Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women.
Myer L; Daskilewicz K; McIntyre J; Bekker LG
J Int AIDS Soc; 2013 Sep; 16(1):18649. PubMed ID: 24044627
[TBL] [Abstract][Full Text] [Related]
18. Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother-to-child transmission of HIV in the Dominican Republic.
Schmidt NC; Roman-Pouriet J; Fernandez AD; Beck-Sagué CM; Leonardo-Guerrero J; Nicholas SW
Int J Gynaecol Obstet; 2012 Mar; 116(3):219-22. PubMed ID: 22196992
[TBL] [Abstract][Full Text] [Related]
19. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
[TBL] [Abstract][Full Text] [Related]
20. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
Wilkinson D; Floyd K; Gilks CF
S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
